K2 HealthVentures Equity Trust LLC 13D and 13G filings for Corbus Pharmaceuticals Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:05 pm Sale |
2024-09-30 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
K2 HealthVentures Equity Trust LLC | 2,873 0.020% |
-339,240 (-99.16%) |
Filing |
| 2024-02-14 4:45 pm Purchase |
2023-12-31 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
K2 HealthVentures Equity Trust LLC | 342,113 7.500% |
342,113 (New Position) |
Filing |